BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22507948)

  • 1. Outcomes of HIV-infected patients treated for recurrent tuberculosis with the standard retreatment regimen.
    McGreevy J; Jean Juste MA; Severe P; Collins S; Koenig S; Pape JW; Fitzgerald DW
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):841-5. PubMed ID: 22507948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for patients with multidrug-resistant tuberculosis in post-earthquake Port-au-Prince, Haiti.
    Charles M; Vilbrun SC; Koenig SP; Hashiguchi LM; Mabou MM; Ocheretina O; Pape JW
    Am J Trop Med Hyg; 2014 Oct; 91(4):715-21. PubMed ID: 25071001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
    Jones-López EC; Ayakaka I; Levin J; Reilly N; Mumbowa F; Dryden-Peterson S; Nyakoojo G; Fennelly K; Temple B; Nakubulwa S; Joloba ML; Okwera A; Eisenach KD; McNerney R; Elliott AM; Ellner JJ; Smith PG; Mugerwa RD
    PLoS Med; 2011 Mar; 8(3):e1000427. PubMed ID: 21423586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes across the tuberculosis care continuum among adolescents in Haiti.
    Reif LK; Rivera V; Bertrand R; Rouzier V; Kutscher E; Walsh K; Charles B; Pape JW; Fitzgerald DW; Koenig SP; McNairy ML
    Public Health Action; 2018 Sep; 8(3):103-109. PubMed ID: 30271725
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study.
    Peck RN; Luhanga A; Kalluvya S; Todd J; Lugoba S; Fitzgerald DW; Downs JA
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1047-51. PubMed ID: 22691942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti.
    Rivera VR; Lu L; Ocheretina O; Jean Juste MA; Julma P; Archange D; Moise CG; Homeus F; Phanor PD; Petión S; Cremieux PY; Fitzgerald DW; Pape JW; Koenig SP
    Int J Tuberc Lung Dis; 2019 Nov; 23(11):1217-1222. PubMed ID: 31718759
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.
    Català L; Orcau A; García de Olalla P; Millet JP; Rodríguez-Mondragón A; Caylà JA;
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):263-9, i. PubMed ID: 21219692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.
    Rivera VR; Jean-Juste MA; Gluck SC; Reeder HT; Sainristil J; Julma P; Peck M; Joseph P; Ocheretina O; Perodin C; Secours R; Duran-Mendicuti M; Hashiguchi L; Cremieux PY; Koenig SP; Pape JW
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):1140-1146. PubMed ID: 29037294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda.
    Luzze H; Johnson DF; Dickman K; Mayanja-Kizza H; Okwera A; Eisenach K; Cave MD; Whalen CC; Johnson JL; Boom WH; Joloba M;
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):361-7. PubMed ID: 23407224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis re-treatment outcomes within the public service in Nairobi, Kenya.
    Chakaya JM; Kibuga D; Ng'ang'a L; Githui WA; Mansoer JR; Gakiria G; Kwamanga D; Maende J
    East Afr Med J; 2002 Jan; 79(1):11-5. PubMed ID: 12380864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.